For several years, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been making waves in the scientific community. Its ability to precisely edit genes has been utilized for accelerating drug discovery and development. Not only is CRISPR proving useful as a tool for the discovery of new treatment targets and for the development of potential therapies but it is also playing a role in some of the actual therapies being developed. Dr Christopher Vakulskas at IDT explains why this is especially true with cell and gene therapies being investigated using a
combination of CRISPR and regenerative medicine techniques.
[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/11/CRISPR-Advances-Can-Accelerate-Biopharmaceutical-Drug.pdf” width=”100%” height=”900px” style=”border:0;”]